Turnstone Biologics has filed a notice of an Initial Public Offering of securities to raise $80,000,000.00 in new Equity.
According to filings with the U.S. Securities and Exchange Commission, Turnstone Biologics is raising $80,000,000.00 in new funding. About Turnstone Biologics: Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure…